Spotlight on IGCS Fellows & Mentors

The IGCS Member Spotlight is back, now with a focus on Fellows and International Mentors participating in the IGCS Global Curriculum & Mentorship Program.

Ricardina Rangeiro
Hospital Central de Maputo
Maputo, Mozambique
Fellow of the IGCS Global Curriculum & Mentorship Program

Where did you complete your training? Or tell us about your background in gyn oncology.
I’m doing my training in Mozambique that I started in 2018. 

Why did you decide to pursue a career in gyn oncology or what about it interested you?  
I’ve always been interested in oncology and during my residency, I’ve noticed that the patients arrived in advanced stages, so I thought what could I do to make a change. 

Tell us about your work in women’s cancer: daily activities and/or special projects.
I work in a ward that take care of women with gynecological cancer. Every day we do rounds, stage the patients with cancer, do biopsies. We also do colposcopies and leeps in the clinic of pre-invasive lesions. Twice a week we do surgeries. 

Tell us about the person or people who have inspired you the most in your career.
My mother, she is a pediatrician and the person responsible for my love of medicine.  

What is the most rewarding part of your career?
The most rewarding part of my career is being capable to treat and relieve the pain of our patients and being able to help these women. 

What is the most beneficial resource or equipment you have access to at your training site?
The most beneficial resource or equipment we have access to is the big volume of patients and radiotherapy. 

What is one of the biggest challenges in gyn cancer care in your region? What resources are lacking?
One of the biggest challenges in gyn cancer care in my region is that there isn’t enough trained medical staff. There is only 1 radiotherapy center for the entire country, and the pathology center with the best trained pathologists is only available in Maputo. 

How long have you been a member and how did you become involved with IGCS?
I’ve known IGCS when I started the program. 

Is there a story/example of a time you were especially proud of your involvement with IGCS?
I’m always proud of my involvement with IGCS. It’s been such an honor to be part of this program and being able to make a huge change in cancer care of gynecology patients. 

What does being a part of the IGCS Global Curriculum & Mentorship Program mean to you?
Being part of the IGCS Global Curriculum & Mentorship Program means I’m being trained by the best in this area, which is a unique experienceIt means a lot to have access to mentors and their guidance because we can get the tools we need to treat thpatients 

Do you have any hobbies or is there an interesting fact about your life that you’d like to share?
Apart from medicine, I like to run. It’s my moment, only mine, to recharge my battery. And of course, enjoy quality time with family and friends. 

What is a unique or fun fact about your country or community culture?
We are a resilient people; against all odds, we get up every day and get the job done with a smile on our faces 

Does your country/region have a traditional food or drink? Do you like it?
Yes, our prawns are one of the best in the worldZambezian chicken prepared with coconut milk, our matava and drinks we have maheu that is made with corn flour are also good. 

 

See more Member Spotlights.

Would you like to be featured in the Member Spotlight? We’d love to hear your story! Complete this form.

Fellows and Mentors in the IGCS Global Curriculum & Mentorship Program should complete this form which includes additional prompts about the program.

Global Health Equity

The International Gynecologic Cancer Society stands at the forefront in the global fight against gynecologic cancers, supporting and sponsoring programs “to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness.”

Consistent with this mission and the current heightened global awareness of, and attention to, social and health inequity, IGCS is issuing this statement outlining its position on these important matters. Most succinctly put, IGCS supports all who espouse social and health equity around the globe.

Our statement provides clear context and specificity to our longstanding and forward-moving embrace of these important social justice and human right imperatives. We hope that it stimulates dialogue/discourse, and we welcome your comments. Most importantly, we hope that it prompts programming and actions that improve the lives of girls, women, and communities worldwide.

We would like to thank the working group for drafting the statement:

  • Dr. Andreas Obermair (Australia)
  • Dr. Marie Plante (Canada)
  • Dr. Michael Quinn (Australia)
  • Dr. Ritu Salani (USA)
  • Ms. Mary (Dicey) Jackson Scroggins (USA)

To continue the discourse, add to the literature, and prompt discussion and most importantly action, IGCS is currently drafting an article focused on global health disparities. The article will:

  • elucidate IGCS’ position more completely
  • site and explore specific systemic patterns and institutions that support or perpetuate inequities
  • highlight areas of women’s well-being that go beyond gynecologic cancer but are integral to their health and that of their communities
  • offer an action plan for moving forward.

In the coming weeks, we will review IGCS operations and programming for areas of potential improvement relative to issues of global health equity. Where appropriate and needed, we will enhance or restructure these areas such that they more explicitly align with our core belief that global health equity is a social justice and human rights imperative—one that we fully support.

After these initial assessments, we will regularly monitor programming and new program development for consistency with our core values summarized in the statement and with the attainment of documentable enhanced global health equity. Of course, we will keep members informed of this ongoing effort, programming adjustments, and progress in this important work. And, we will need and request your help in this organization-wide commitment to global health equity.

Statement

Global Health Equity: A Social Justice and Human Rights Imperative

IGCS Supports All Who Espouse Social and Health Equity Around the Globe 

As a core principle, the concept of global health equity—the absence of systematic disparities in health to allow the opportunity for every person to attain her (or his) full health potential—is embedded in the mission of the International Gynecologic Cancer Society (IGCS) and is reflected in the breadth of our membership and the design and implementation of our programs.

With over 3,100 members from low-, middle-, and high-income countries around the globe, IGCS has purposefully developed an inclusive membership framework that encourages interaction and growth across diverse social, political, and health care systems. Through this framework, IGCS connects our members with specific needs to those with corresponding resources and programs; forms partnerships; educates, trains, and mentors clinicians, survivors-patients, and caregivers; and otherwise enhances benefits to women not only in optimal but also in the most challenging circumstances and environments.

Since our establishment in 1987 as a forum for the worldwide exchange of scientific information, IGCS has grown as a model for global health equity, and consistent with that history and our current operation, IGCS supports individuals and organizations meaningfully engaged, at whatever level, in the journey toward social and health equity worldwide.

As we lead the global fight against gynecologic cancers, we do so with the clear understanding that prompting, promoting, and inspiring maximum achievable health outcomes for every girl and woman (and thus every community)—wherever and under whatever circumstance she might live—are fundamental to the social justice and human rights imperative of global health equity, irrespective of

  • national origin or political system
  • location of residence/citizenship
  • race or ethnicity
  • religion
  • sexual orientation and/or gender identity
  • local, national, or regional leadership
  • sociodemographic factors
  • geopolitics
  • any other intervening factor

In keeping with this understanding and by focusing our work and service where they can have the greatest impact on health and well-being, IGCS supports the empowerment of girls and women—and the health professionals who serve them—so they can attain the best health and life outcomes specific to but not limited to gynecologic cancers.

In the coming weeks and months, IGCS will review our programming. Furthermore, as an act of social responsibility, we will continually review the health equity-explicit initiatives within our portfolio and identify the need for new initiatives where none exist. After all, our mission “to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness” and our demonstrated commitment to global health equity explicitly require as much.

Download PDF of this statement.

IGCS 2020 Post-Meeting

The 2020 IGCS Annual Global Meeting was a great success with nearly 2,000 registered delegates. We are so proud that our digital platform allowed nearly 200 speakers to share their research and expertise reaching the gynecologic cancer community worldwide.

We are extremely grateful to our technology partners at iCrossing, Inc. for their hard work and dedication in developing the Meeting Portal and their support to our staff, speakers and delegates throughout the duration of the meeting. We could not have done it without them.

Here is some important post-meeting information for the delegates. Delegate who have questions or need assistance regarding the meeting, please send an email to help@igcsmeeting.com.

Claim Continuing Medical Education Credits

Before September 25,2020:

  1. Click on the following link: EVALUATION FORM
    Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended. If you are unable to complete the evaluation link above, download the PDF evaluation form here: https://www.bluevents.it/documenti/documenti/evaluation-form—eaccme.pdf 
  1. Complete the online evaluation form and hit submit.
  2. The CME/CPD certificate will be sent via email once received the form duly filled in.

E-mail: igcs2020@bluevents.it for assistance with CME. Read more about CME Accreditation here. 

Certificate of Attendance

A certificate of attendance was emailed to all delegates on September 17th from icrossing@igcsmeeting.com.

View Session Recordings

Session recordings are available within the meeting portal, separated by the channel where the session originally aired and will be available until October 9th via the congress portal, using your login details.

Simply navigate to the sessions, select the channel you are interested in, then click the button in the top right-hand corner. You will be taken to the channel catch-up page where you can access all the sessions from this channel.

Access Links to all Session Recordings Here

 

IGCS 2020 Meeting Access

To access the IGCS 2020 xDigital Annual Global Meeting Portal, go to 2020.igcsmeeting.com

 

Registered Delegates: Your unique access code was sent via email in a message from icrossing@igcsmeeting.com with the subject line “IMPORTANT: DELEGATE PASS – IGCS xDigital.”

If you cannot find the email message with your access code, please check your spam filter first.
If you cannot locate the message, please email help@igcsmeeting.com

💬 Help and support

A dedicated email and live chat will be available to delegates 24 hours a day throughout the congress for any assistance or queries that arise. Access the live chat through the Help and Support page on 2020.igcsmeeting.com when the congress portal is open or email us at help@igcsmeeting.com.

🖥️ Browser Requirements

The browsers listed below are compatible with the congress portal:
• Windows: Edge 12+, IE 11+, Firefox 27+, Chrome 30+
• Mac: Recommended: Chrome 30+ (Safari is not supported)
• Linux: Firefox 27+, Chrome 30+

💻 Operating System Requirements

Check your computer’s operating system before the start of the congress to ensure the software works with the congress portal. See below list of compatible operating systems:
• MacOS X with macOS 10.7 or later
• Windows 10*, 8.1, 8, 7
• Red Hat Enterprise Linux 6.4 or higher
• iOS 7.0 or later
• iPadOS 13 or later
• Android 4.0x or later

*Windows 10 Home, Pro or Enterprise only. S Mode is not supported.

Symposium – Desktop device
We recommend viewing the symposium on your desktop device for the best experience.

Disclaimer
The xDigital platform is a unique, custom-built environment that leverages a number of different technologies. One of these technologies is Zoom. Please check your company usage policies if you are using company equipment to access the congress. If Zoom is prohibited, you will need to request special dispensation to use it, or arrange an alternative device.

IGCS 2020 Abstracts

Download the abstracts to be presented at the IGCS 2020 Annual Global Meeting:

Download the Program Book.

Learn more about IGCS 2020 and register at igcsmeeting.com.

Frequently Asked Questions

Registered delegates should have received their unique login code to access the Meeting Portal via email from icrossing@igcsmeeting.com on or after September 2nd, depending on when they registered. If you have not received the email, please check your spam filter first. If you have not received your code, email help@igcsmeeting.com for assistance.

2020 Award Recipients

These award recipients will be recognized at the upcoming xDigital Annual Global Meeting of the International Gynecologic Cancer Society which will be held in a fully digital setting this September 10-13, 2020. The Awards Ceremony will take place during the Opening Ceremony on September 10th at 2:00 p.m. UCT.

Please join us in congratulating them on their achievements!

2020 Lifetime Achievement Award Recipients

Monica Bacon, RN
Canada

Co-Founder of the Gynecologic Cancer InterGroup (GCIG), Ms. Bacon is a recipient of the IGCS 2020 Lifetime Achievement Award for her lifelong dedication to women’s health and serving the gynecologic cancer community though nursing, clinical trial coordination and international team building, advocacy, and volunteerism.

Read more about Monica.

Nicoletta Colombo, MD, PhD
Italy

Principle investigator of several international clinical trials and established author, Professor Colombo is the recipient of the IGCS 2020 Lifetime Achievement Award for her exemplary leadership in multiple gynecologic oncology organizations, and lifelong commitment to science, research and clinical trials.

Read more about Nicoletta.

2020 Excellence in Teaching Award Recipient

Rahel Ghebre, MD, MPH
USA

For her mentorship and leadership with gynecologic oncology sub-specialty training programs in Ethiopia, specifically at Addis Ababa University and initiating a program at St. Paul’s Millenium Medical College. This award recognizes a deep commitment and dedication to gynecologic oncology, exemplifying the core components of teaching and education.

Read more about Rahel.

2020 Distinguished Advocacy Award Recipients

Runcie C.W. Chidebe & Project PINK BLUE
Nigeria
For outstanding advocacy throughout Nigeria and in global forums, including founding Project PINK BLUE—an organization focused on cancer advocacy, oncology training, and research—as well as influencing the establishment of the National Institute for Cancer Research and Treatment, developing numerous programs to serve the most needy, and changing cancer awareness and care throughout Nigeria

Read more about Runcie & Project PINK BLUE.

Nathalie Dauphin McKenzie, MD (USA) &
Innovating Health International (Haiti)
For courageous, ongoing advocacy for survivors-patients in the USA and Haiti, including traveling to Haiti several times a year—at great personal risk—to perform life-saving surgeries (otherwise unavailable) and to train oncologists to do the same, currently primarily through Innovating Health International, a Port-au-Prince based women’s cancer center, where no patient is ever turned away because of treatment costs

Read more about Nathalie & Innovating Health International.

Ovarian Cancer Research Alliance
For dedicated service to advocate and research communities, as the largest global, non-government funder of ovarian cancer research, having raised over $100 million for research/services and developed and conducted extensive advocacy programs including Survivors Teaching Students® through which ovarian cancer survivors and family members have trained/reached nearly 100,000 medical and other health professions students

Read more about the Ovarian Cancer Research Alliance.

2020 IJGC Award Recipients

The International Journal of Gynecological Cancer (IJGC) is a joint publication of the International Gynecologic Cancer Society (IGCS) and the European Society of Gynaecological Cancer (ESGO). The IJGC Awards are presented at the IGCS and ESGO Annual Meetings on alternate years. This year, the IJGC Awards will be presented at the 2020 IGCS Annual Global Meeting.

Most Downloaded Paper Award (2020)

Gloria Salvo, MD
for the paper titled
“Updates and management algorithm for neuroendocrine tumors of the uterine cervix”

Editor’s Choice Award (2020)

David Cibula, MD, PhD
for the paper titled
“European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer”

View Top 10 Journal Reviewers of 2020

Commentary: COVID-19 Vaccination

The 4th of June was a red- letter day for the world, particularly for the world’s children and for a global community beset with COVID-19. Participants at GAVI’s third donor pledging Global Vaccine Summit, included 42 heads of state and all the leaders of the G7 and G20 nations who pledged US$ 8.8 billion to protect the world’s most vulnerable children from infectious disease.

At the same time, world leaders pledged an additional US$ 567 million in initial seed money to support the Gavi Covax AMC  which will ensure that people in low- and lower middle-income countries get access to COVID-19 vaccines once they are licensed.

The benefits of vaccination against infectious diseases which particularly strike children in low and middle- income countries are obvious to us all. The elimination of smallpox, the virtual elimination of polio and the drastic reduction in diphtheria, tetanus and rubella stand as testimony to the science and to the vision of the WHO and philanthropists such as Bill and Melinda Gates.

But all is not what it seems. Recently published in the International Journal of Gynecological Cancer, a commentary article by Keiichi Fujiwara and Michael Quinn highlights the potential for disruption to any successful COVID-19 roll-out by what is an increasingly robust and well-resourced anti-vaccine lobby using the illustration of Japan and HPV vaccination.

COVID-19 infection has special implications for cancer patients and for pregnant women. IGCS believes that any vaccine program will be adequately tested before introduction and has the potential to significantly reverse the huge social and health impacts of COVID-19. We urge our members worldwide to ensure that their political leaders are not swayed with false information and to facilitate any new vaccine uptake.

IGCS COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download: IGCS Survey on the Impact of COVID-19 on Gynecologic Cancer Care Executive Summary July 2020

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

Education Highlight: In the Know

This month’s Education Highlight is from In the Know (Ed’s List)

In the Know is prepared by Edward Pavlik, PhD, Professor and Director of Ovarian Screening Research Program, University of Kentucky on a monthly basis. Ed’s lists provide a compilation of abstracts related to the field of gynecologic oncology from multiple scholarly journals.

Here’s an example of one abstract from the June 2020 In the Know compilation:

Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. MP Salcedo, AK Sood, A Jhingran, PJ Eifel, AH Klopp, RB Iyer, BM Fellman, C Jimenez, KM Schmeler. Cancer, (2020) 126: 2607-2613. doi:10.1002/cncr.32807 https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32807

Background  Advances in radiotherapy (RT) have led to improved oncologic outcomes for women with gynecologic cancers; however, the long‐term effects and survivorship implications need further evaluation. The purpose of this study was to determine the incidence of pelvic fractures and changes in bone mineral density (BMD) after pelvic RT.

Methods  Two hundred thirty‐nine women who had pelvic RT for cervical, endometrial, or vaginal cancer between 2008 and 2015 were prospectively studied. BMD scans and biomarkers of bone turnover were obtained at the baseline and 3 months, 1 year, and 2 years after RT. Imaging studies were assessed for pelvic fractures for up to 5 years. Patients with osteopenia, osteoporosis, or pelvic fractures at any point were referred to the endocrinology service for evaluation and treatment.

Results  The median age at diagnosis was 51 years; 132 patients (56%) were menopausal. The primary diagnoses were cervical (63.6%), endometrial (30.5%), and vaginal cancer (5.9%). Sixteen patients (7.8%; 95% confidence interval, 4.5%‐12.4%) had pelvic fractures with actuarial rates of 3.6%, 12.7%, and 15.7% at 1, 2, and 3 years, respectively. Fractures were associated with baseline osteoporosis ( < .001), higher baseline bone‐specific alkaline phosphatase ( < .001), and older age ( = .007). The proportion of patients with osteopenia/osteoporosis increased from 50% at the baseline to 58%, 59%, and 70% at 3 months, 1 year, and 2 years, respectively.

Conclusions  A high proportion of women had significant decreases in BMD after pelvic RT, with 7.8% diagnosed with a pelvic fracture. BMD screening and pharmacologic intervention should be strongly considered for these high‐risk women.

Stay “In the Know” and keep up with Ed’s List in the Members-Only IGCS Literature Library. Click here to login to the Member’s Education Portal and access the entire archive.

Leading Together

President’s Perspective

IGCS Members and Friends,

We are all on a journey with COVID-19. All over the world, our way of life is changing, and priorities are shifting.

There is still so much to learn, behavior to change, data to gather and analyze, all while trying to reassemble our lives both personally and professionally within this new era marked by a virus. The last several months are unlike anything most of us have experienced in our lifetimes. The only certainty today is uncertainty – and this is going to take time, lots of time.

To undertake this journey, we must be multidimensional and adapt boldly to the changing circumstances. This includes being acutely self-aware, insatiably curious, authentic, resilient, flexible, and courageous. Now more than ever, the world needs strong leadership, decisive action, innovative ideas, and effective communication.

Many of you may find yourselves in leadership positions with your colleagues, divisions and departments, your friends and even your families. Priorities, responsibilities, and roles may have shifted dramatically in the past several months. Effective leaders are now more important than ever.

As an organization, the IGCS is no different. We have taken the lead in transforming our Annual Global Meeting to a fully digital meeting because we believe in the importance of sharing data and science, uniting the gynecologic cancer community, and continuing to focus on our patients in these times of uncertainty.

I am grateful to the IGCS Council for being my partners in leading the society through this trying time, making tough decisions, assessing risk, and moving forward swiftly and decisively. I must also acknowledge the IGCS staff who have been relentless in leading our efforts to transform IGCS not only from the Annual Meeting perspective but organizationally as well.

IGCS xDigital Annual Global Meeting
September 10-13, 2020

The IGCS xDigital Meeting will be held this September and I hope that you all will join us and experience our innovative new meeting portal. We have been quick to adapt our regular meeting format to accommodate the needs of our members and partners and we are excited to deliver a unique meeting experience with “xDigital” technology that is so much more than a webinar.

  • The program will feature multiple simultaneous sessions (or channels) and delegates can easily move from one session room to another.
  • The sessions are scheduled for different time zones each day to accommodate our global audience.
  • The main sessions are equipped with audience participation features such as live polls and Q&A.
  • Delegates will be able to connect and communicate with each other within the meeting portal.
  • A digital exhibition hall will be brought to life with 3D rendered spaces and delegates will be incentivized to visit all the exhibit booths where they can access videos and downloadable materials and schedule meetings with industry representatives.

Registration

One major benefit of this new format is that the cost of attendance is significantly lower than it would be to travel and attend a physical meeting and we hope that this will make the IGCS Meeting more accessible than ever for our members and friends around the world. In true IGCS fashion, we are collaborating with many regional groups to offer group registration packages as well.

Abstract and Surgical Film Submission

Abstracts and surgical films are being accepted through July 15 and late-breaking abstracts will be accepted from July 25-August 15.  Late-breaking abstracts should contain new information that was not available prior to the general deadline. Don’t miss your chance to lead the way and present at the first IGCS xDigital Meeting!

Now is the time to come together (digitally) to share our experiences, discuss lessons learned, and meet the challenges we face head-on. With our combined expertise, creativity, and compassion, we will lead together through these trying times. We are making plans for IGCS to gather in Rome in 2021 and I truly hope to see you all there face-to-face but until then help us lead IGCS into a new era, new way of conducting education and disseminating vital knowledge.

Sincerely,

Roberto Angioli, MD
2018-2020 IGCS President